Paul F. Truex's most recent trade in Milestone Pharmaceuticals Inc was a trade of 45,072 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 31, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc | Paul F. Truex | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2022 | 45,072 | 0 | - | - | Stock Option (right to buy) | |
| Milestone Pharmaceuticals Inc | Paul F. Truex | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.54 per share. | 31 May 2022 | 45,072 | 53,088 (0%) | 0% | 1.5 | 69,411 | Common Shares |
| Milestone Pharmaceuticals Inc | Paul F. Truex | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2022 | 22,870 | 2,659 | - | - | Stock Option (right to buy) | |
| Milestone Pharmaceuticals Inc | Paul F. Truex | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.54 per share. | 31 May 2022 | 22,870 | 75,958 (0%) | 0% | 1.5 | 35,220 | Common Shares |
| Milestone Pharmaceuticals Inc | Paul F. Truex | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 31 May 2022 | 8,016 | 8,016 (0%) | 0% | 1.1 | 8,978 | Common Shares |
| Milestone Pharmaceuticals Inc | Paul F. Truex | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2022 | 8,016 | 0 | - | - | Stock Option (right to buy) | |
| Milestone Pharmaceuticals Inc | Paul F. Truex | Director | Purchase of securities on an exchange or from another person at price $ 5.60 per share. | 31 May 2022 | 5,000 | 81,780 (0%) | 0% | 5.6 | 28,000 | Common Shares |
| Milestone Pharmaceuticals Inc | Paul F. Truex | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2022 | 822 | 117 | - | - | Stock Option (right to buy) | |
| Milestone Pharmaceuticals Inc | Paul F. Truex | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.66 per share. | 31 May 2022 | 822 | 76,780 (0%) | 0% | 2.7 | 2,187 | Common Shares |
| Milestone Pharmaceuticals Inc | Paul F. Truex | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Paul F. Truex | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 32,000 | 32,000 | - | - | Stock Option (right to buy) |